| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/15/1992 | CA2025398A1 Diagnosis and treatment of a disorder of the gastrointestinal tract |
| 03/14/1992 | WO1992005178A1 Synthetic drug molecules that mimic metalloenzymes |
| 03/14/1992 | WO1992005172A2 Muscarinic receptor antagonists |
| 03/14/1992 | WO1992005156A1 Pyridylthio or pyridyloxy alkanoic acids |
| 03/14/1992 | CA2092697A1 Synthetic drug molecules that mimic metalloenzymes |
| 03/14/1992 | CA2091246A1 Indole ureas as 5 ht receptor antagonist |
| 03/14/1992 | CA2089728A1 Pyridylthio or pyridyloxy alkanoic acids |
| 03/14/1992 | CA2068527A1 Muscarinic receptor antagonists |
| 03/14/1992 | CA2051311A1 Treatment of asbestos and silicates to reduce their toxicity |
| 03/14/1992 | CA2050994A1 3-aryl-4(3h)quinazolinone cck antagonists and pharmaceutical formulations thereof |
| 03/14/1992 | CA2050739A1 Squalene synthetase inhibitors |
| 03/13/1992 | WO1992004369A1 5-aminosalicylic acid derivatives for the therapy of chronic inflammatory bowel diseases |
| 03/13/1992 | WO1992004362A1 2-hydroxy- and 2-acyloxy-4-morpholinyl anthracyclines |
| 03/13/1992 | WO1992004359A2 Monosaccharides having anti-proliferation and anti-inflammatory activity, compositions and uses thereof |
| 03/13/1992 | CA2091587A1 Monosaccharides having anti-proliferation and anti-inflammatory activity, compositions and uses thereof |
| 03/13/1992 | CA2091459A1 5-aminosalicylic acid derivatives for the therapy of chronic inflammatory bowel diseases |
| 03/13/1992 | CA2088979A1 2-hydroxy- and 2-acyloxy-4-morpholinyl anthracyclines |
| 03/13/1992 | CA2051091A1 Utilization of n-(1-hexahydroazepinylalkyl)acetamides for preparing drugs used for treating cholinergic transmission troubles |
| 03/13/1992 | CA2050721A1 28-hydroxy ivermectin aglycone |
| 03/12/1992 | WO1992004349A1 Therapeutic agents |
| 03/12/1992 | WO1992004021A1 Method for providing improved analgesic effect |
| 03/12/1992 | DE4028866A1 Neue leukotrien-b(pfeil abwaerts)4(pfeil abwaerts)-antagonisten, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel New leukotriene b (Down Arrow) 4 (down arrow) antagonists, process for their production and their use as drug |
| 03/12/1992 | DE4028864A1 Verfahren zur herstellung von e/z-mischungen von 2-(6-alkyl-bicyclo-(3.3.0)-octan-3-yliden) -essigsaeure-derivaten mit ueberwiegendem anteil des e-isomeren Process for the preparation of e / z of mixtures of 2- (6-alkyl-bicyclo (3.3.0) octane-3-ylidene) with a predominant proportion of e-isomeric acetic acid derivatives |
| 03/12/1992 | DE4028398A1 Phenylethanolamine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung Phenylethanolamine, pharmaceutical compositions containing them and methods for their manufacture |
| 03/12/1992 | CA2088777A1 Therapeutic agents |
| 03/11/1992 | WO1992004365A1 Mometasone furoate monohydrate, process for making same and pharmaceutical compositions |
| 03/11/1992 | WO1992004321A1 Substituted bicyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity |
| 03/11/1992 | WO1992004315A1 Substituted monocyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity |
| 03/11/1992 | WO1992004040A1 Treatment of obesity with an alpha-2-adrenergic agonist and a growth hormone releasing peptide |
| 03/11/1992 | WO1992004023A1 Composition and method for protecting the heart during reperfusion |
| 03/11/1992 | EP0474597A2 Diphenyl compounds as inhibitors of the arachidonic acid pathway and their use in pharmaceutical compositions |
| 03/11/1992 | EP0474580A2 Use of 1-[3-(dimethylamino)propyl]-1-phenylphthalenes for the treatment of cerebrovascular disorders |
| 03/11/1992 | EP0474561A1 Arylalkylamines, process for their preparation and pharmaceutical compositions containing them |
| 03/11/1992 | EP0474553A1 Actinonin derivatives |
| 03/11/1992 | EP0474517A2 Novel use of 1alpha-hydroxylated-19-nor-vitamin D compounds to treat psoriasis |
| 03/11/1992 | EP0474438A1 Method for preventing or treating cerebrovascular disease employing the ACE-inhibitor ceronapril |
| 03/11/1992 | EP0474403A1 Method of treating inflammatory bowel disease |
| 03/11/1992 | EP0474374A1 Method for treatment of bone wasting diseases using a progestin |
| 03/11/1992 | EP0474358A2 Use of conduritol to inhibit an increase in blood sugar level |
| 03/11/1992 | EP0474323A1 Reducing chelants, their complexes with technetium and rhenium, method for their preparation and their use in diagnosis and therapy |
| 03/11/1992 | EP0474291A1 HMG-COA reductase inhibitor metabolites |
| 03/11/1992 | EP0474243A1 1-Methylcarbapenem derivatives and process for preparation thereof |
| 03/11/1992 | EP0474126A1 Ointments containing tricyclic compound |
| 03/11/1992 | EP0474109A1 New 5-benzyl-substituted benzimidazolin-2-thion derivatives and process for their preparation |
| 03/11/1992 | EP0474098A1 Controlled drug release composition |
| 03/11/1992 | EP0474063A1 Dialkoxybenzylidene campher derivatives |
| 03/11/1992 | EP0474049A1 Antibiotic C-3 catechol-substituted cephalosporin compounds, compositions and use thereof |
| 03/11/1992 | EP0474038A1 New 2-tert. substituted methyloxapenem-3-carboxylic acids and esters, their preparation and use |
| 03/11/1992 | EP0474013A1 Process for the preparation of crystalline TACS |
| 03/11/1992 | EP0474012A1 6,7-Dihydro-3-phenyl-1,2-benzisoxazol-4(5H)-ones and -ols, a process for their preparation and their use as medicaments |
| 03/11/1992 | EP0473963A1 Pyrrolobenzimidazoles, imidazobenzoxazinones, and imidazoquinolones, processes for their preparation and their use as well as compositions containing these compounds |
| 03/11/1992 | EP0473936A1 Renin Inhibitors |
| 03/11/1992 | EP0473844A1 Medicament containing a combination of AZT and amantadin for the treatment of AIDS |
| 03/11/1992 | EP0473825A1 Non-solvated crystalline form "A" of 3-(-4-cinnamyl-1-piperazinyl)-iminomethylrifamycins and process for the preparation thereof |
| 03/11/1992 | EP0473811A1 Ointment containing deprodone proprionate |
| 03/11/1992 | EP0473810A1 Water and deprodone proprionate -containing external preparations |
| 03/11/1992 | EP0473707A1 Injectable clarithromycin composition |
| 03/11/1992 | EP0473673A1 Method for protection from azt side effects and toxicity |
| 03/11/1992 | EP0473671A1 Use of sigma-receptors ligands for the manufacture of an anxiolytic agent. |
| 03/11/1992 | EP0473626A1 New diphosphonic acid derivatives, process for producing them and drugs containing them. |
| 03/11/1992 | EP0473604A1 Onset-hastened/enhanced antipyretic response |
| 03/11/1992 | EP0473576A1 SHORT THERAPEUTIC dsRNA OF DEFINED STRUCTURE |
| 03/11/1992 | EP0466768A4 Short-chain triglycerides |
| 03/11/1992 | EP0455753A4 Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration |
| 03/11/1992 | EP0436611A4 Compound and method for the retardation of collagen cross-linking |
| 03/11/1992 | EP0422097A4 Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo |
| 03/11/1992 | EP0392006A4 Method of making a free-flowing spray-dried edible powder comprising an oil |
| 03/11/1992 | EP0386000B1 Controlled release of antibiotic salts from an implant |
| 03/11/1992 | EP0169214B1 Anti-oestrogen drug for percutaneous administration |
| 03/11/1992 | CN1059338A Cantharidin fat-soluble medicament preparation |
| 03/11/1992 | CN1059337A Water soluble derivatives of taxol |
| 03/11/1992 | CN1059279A Liposomes that provide thymic dependent help to weak vaccine antigens |
| 03/11/1992 | CN1059277A Local drug delivery compositions for dental use |
| 03/11/1992 | CN1059276A Pharmaceutical composition of florfenicol |
| 03/11/1992 | CN1015804B Method for preparation of sulphonic acid amide compound for antiarrhythmic agent |
| 03/11/1992 | CA2091257A1 Substituted bicyclic aryl compounds exhibiting selective leukotriene b4 antagonists activity |
| 03/11/1992 | CA2091256A1 Substituted monocyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity |
| 03/11/1992 | CA2068333A1 Composition and method for protecting the heart during reperfusion |
| 03/11/1992 | CA2051034A1 Pharmaceutical formulation containing a benzoyl urea derivative |
| 03/11/1992 | CA2050977A1 Substituted 3-aminosydnone imines, process for their preparation and their use |
| 03/11/1992 | CA2050962A1 Aryl-fused and hetaryl-fused-2,4 diazepine and 2,4-diazocine antiarrhythmic agents |
| 03/11/1992 | CA2050858A1 Benzodiazepines |
| 03/11/1992 | CA2050769A1 Azacyclic compounds |
| 03/11/1992 | CA2050723A1 Angiotensin ii receptor antagonists |
| 03/11/1992 | CA2050358A1 Lubricant composition and use thereof |
| 03/10/1992 | US5095137 Amides of cyclomethylen-1,2-bicarboxylic acids having therapeutical activity |
| 03/10/1992 | US5095129 Antiglucocorticoid, antimineralcorticoid, antiandrogen |
| 03/10/1992 | US5095127 Process for producing polycyclic ether antibiotics |
| 03/10/1992 | US5095115 Preparation of riboflavin 5'-phosphate (fmn) and its sodium salt in a lactone |
| 03/10/1992 | US5095112 Process for the preparation of quinolonecarboxylic acid esters |
| 03/10/1992 | US5095108 Non-solvated crystalline form "A" of 3-(4-cynnamyl-1-piperazinyl)iminomethylrifamycine SV and a method of its production |
| 03/10/1992 | US5095106 Olgiosaccharide inhibition of Streptococcus pyogenes adhesion |
| 03/10/1992 | US5095039 Diphenylsulfide compound and use |
| 03/10/1992 | US5095037 Combined anti-inflammatory agent |
| 03/10/1992 | US5095035 Sweet carrier |
| 03/10/1992 | US5095034 Saccharoascorbic acid derivative |
| 03/10/1992 | US5095033 Side effect reduction |
| 03/10/1992 | US5095032 Parasiticidal new substituted thienopyranones |
| 03/10/1992 | US5095031 Indole derivatives which inhibit leukotriene biosynthesis |
| 03/10/1992 | US5095027 Antiischemic |